Welcome to our dedicated page for XWELL news (Ticker: XWEL), a resource for investors and traders seeking the latest updates and insights on XWELL stock.
XWELL, Inc. develops wellness and biosecurity services for travelers, commuters, and other people moving through high-traffic locations. Recurring updates cover XpresSpa airport spas, Naples Wax Center skincare and waxing locations, wellness retail openings, travel-product collaborations, and partnerships that expand access to services in airports and metropolitan areas.
Company news also covers XpresCheck biosecurity work, including traveler-based pathogen surveillance, nasal sampling, wastewater collection, and forecasting tools used with public health programs. Financial releases discuss revenue by brand, operating expenses, cost controls, capital actions, and corporate updates related to XWELL’s Nasdaq-listed common stock.
XWELL, Inc. (Nasdaq: XWEL) plans to announce its third quarter 2022 financial results on November 10, 2022, after the market closes. Following this announcement, a webcast and conference call will be held at 4:30 PM ET. Investors can participate via a limited-capacity conference call or stream the event live from the Investor Relations section of XWELL's website. The company operates several wellness brands, including XpresCheck, XpresSpa, Treat, and HyperPointe.
Summary not available.
XWELL, Inc. (formerly XpresSpa Group, Inc.) announced its corporate rebranding aimed at establishing itself as a leader in health and wellness. Effective October 25, 2022, the ticker symbol changes from XSPA to XWEL. The rebrand underscores the company's transition towards comprehensive wellness solutions for travelers, aligning with its four transformational imperatives for growth. Recent developments include the reopening of XpresSpa at JFK, new locations in Istanbul and Salt Lake City, and a partnership with Ginkgo Bioworks for COVID-19 genomic surveillance initiatives.